Fuse to defuse: a self-limiting ribonuclease-ring nuclease fusion for type III CRISPR defence
Open Access
- 19 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 48 (11) , 6149-6156
Abstract
Type III CRISPR systems synthesise cyclic oligoadenylate (cOA) second messengers in response to viral infection of bacteria and archaea, potentiating an immune response by binding and activating ancillary effector nucleases such as Csx1. As these effectors are not specific for invading nucleic acids, a prolonged activation can result in cell dormancy or death. Some archaeal species encode a specialised ring nuclease enzyme (Crn1) to degrade cyclic tetra-adenylate (cA4) and deactivate the ancillary nucleases. Some archaeal viruses and bacteriophage encode a potent ring nuclease anti-CRISPR, AcrIII-1, to rapidly degrade cA4 and neutralise immunity. Homologues of this enzyme (named Crn2) exist in type III CRISPR systems but are uncharacterised. Here we describe an unusual fusion between cA4-activated CRISPR ribonuclease (Csx1) and a cA4-degrading ring nuclease (Crn2) from Marinitoga piezophila. The protein has two binding sites that compete for the cA4 ligand, a canonical cA4-activated ribonuclease activity in the Csx1 domain and a potent cA4 ring nuclease activity in the C-terminal Crn2 domain. The cA4 binding affinities and activities of the two constituent enzymes in the fusion protein may have evolved to ensure a robust but time-limited cOA-activated ribonuclease activity that is finely tuned to cA4 levels as a second messenger of infection.Keywords
All Related Versions
Funding Information
- Biotechnology and Biological Sciences Research Council (REF BB/S000313/1)
- RCUK
This publication has 29 references indexed in Scilit:
- Control of cyclic oligoadenylate synthesis in a type III CRISPR systemeLife, 2018
- Programmable RNA recognition using a CRISPR-associated ArgonauteProceedings of the National Academy of Sciences, 2018
- Allosteric regulation of Csx1, a type IIIB-associated CARF domain ribonuclease by RNAs carrying a tetraadenylate tailNucleic Acids Research, 2017
- A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systemsScience, 2017
- Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengersNature, 2017
- Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas systemGenes & Development, 2016
- RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complexGenes & Development, 2016
- Crystal structures of CRISPR-associated Csx3 reveal a manganese-dependent deadenylation exoribonucleaseRNA Biology, 2015
- Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas ImmunityCell, 2015
- Bacterial Toxin RelE: A Highly Efficient Ribonuclease with Exquisite Substrate Specificity Using Atypical Catalytic ResiduesBiochemistry, 2013